{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:30:14Z","timestamp":1784291414476,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004695","name":"Inyuvesi Yakwazulu-Natali","doi-asserted-by":"publisher","award":["MND190618448386"],"award-info":[{"award-number":["MND190618448386"]}],"id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["MND190618448386"],"award-info":[{"award-number":["MND190618448386"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111515","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T17:45:56Z","timestamp":1616262356000},"page":"111515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration"],"prefix":"10.1016","volume":"138","author":[{"given":"Sanelisiwe P.","family":"Xhakaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Khoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advaitaa M.","family":"Haripershad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terisha","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanel","family":"Dhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmas","family":"Mutsimhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molopa J.","family":"Molopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithia P.","family":"Madurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Madurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanil D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala D.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik G.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thavendran","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Chuturgoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooraj","family":"Baijnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111515_bib1","series-title":"Clinical Applications of Mass Spectrometry in Drug Analysis","first-page":"59","article-title":"Quantitation of total buprenorphine and norbuprenorphine in meconium by LC-MS\/MS","author":"Marin","year":"2016"},{"key":"10.1016\/j.biopha.2021.111515_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/00912709922008236","article-title":"Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations","volume":"39","author":"Nath","year":"1999","journal-title":"The Journal of Clinical Pharmacology"},{"key":"10.1016\/j.biopha.2021.111515_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/NDT.S70585","article-title":"Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats","volume":"11","author":"Chen","year":"2015","journal-title":"NDT"},{"key":"10.1016\/j.biopha.2021.111515_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.biopha.2021.111515_bib5","first-page":"859","article-title":"Buprenorphine \u2013 an attractive opioid with underutilized potential in treatment of chronic pain","volume":"8","author":"Khanna","year":"2015","journal-title":"JPR"},{"key":"10.1016\/j.biopha.2021.111515_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s13063-018-3055-z","article-title":"Single high-dose buprenorphine for opioid craving during withdrawal","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.biopha.2021.111515_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111515_bib8","article-title":"Impact of opioid therapy on gonadal hormones: focus on buprenorphine","volume":"36","author":"Varma","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.111515_bib9","first-page":"281","article-title":"Buprenorphine: new treatment of opioid addiction in primary care","volume":"57","author":"Kahan","year":"2011","journal-title":"Can. Fam. Phys."},{"key":"10.1016\/j.biopha.2021.111515_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-018-0953-z","article-title":"Treating chronic pain: an overview of clinical studies centered on the buprenorphine option","volume":"78","author":"Davis","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2021.111515_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chroma.2015.03.056","article-title":"Simultaneous analysis of multiple neurotransmitters by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry","volume":"1395","author":"Tufi","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2021.111515_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneumeth.2011.03.023","article-title":"Development and validation of an ultra-high performance liquid chromatography\u2013tandem mass-spectrometry (UHPLC\u2013MS\/MS) method for the simultaneous determination of neurotransmitters in rat brain samples","volume":"198","author":"Gonz\u00e1lez","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2021.111515_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.2042-7158.2011.01384.x","article-title":"Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model","volume":"64","author":"Sghendo","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111515_bib14","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1039\/c0an00256a","article-title":"Selective detection of neurotransmitter serotonin by a gold nanoparticle-modified glassy carbon electrode","volume":"135","author":"Wei","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.biopha.2021.111515_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fphar.2016.00514","article-title":"Blockade of serotonin 5-HT2A receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice","volume":"7","author":"Pang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111515_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2014.07.038","article-title":"The role of serotonin in adult hippocampal neurogenesis","volume":"277","author":"Alenina","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2021.111515_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuropharm.2015.09.031","article-title":"Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice","volume":"101","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111515_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pharep.2014.11.002","article-title":"Context-controlled nicotine-induced changes in the labeling of serotonin (5-HT) 2A and 5-HT2C receptors in the rat brain","volume":"67","author":"Zaniewska","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2021.111515_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111515_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156720211796558032","article-title":"Dopamine and vascular dynamics control: present status and future perspectives","volume":"8","author":"Khosrow Tayebati","year":"2011","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.biopha.2021.111515_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26801","article-title":"Effects of dopamine on reinforcement learning and consolidation in Parkinson\u2019s disease","volume":"6","author":"Grogan","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2021.111515_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/701377","article-title":"GABA as a neurotransmitter in Gastropod Molluscs","volume":"236","author":"Miller","year":"2019","journal-title":"Biol. Bull."},{"key":"10.1016\/j.biopha.2021.111515_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.1222265","article-title":"BDNF is a negative modulator of morphine action","volume":"338","author":"Koo","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111515_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104521","article-title":"Activation of MORs in the VTA induces changes on cFos expression in different projecting regions: effect of inflammatory pain","volume":"131","author":"Campos-Jurado","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2021.111515_bib25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neubiorev.2009.02.005","article-title":"The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction","volume":"33","author":"Guo","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2021.111515_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jmgm.2019.01.007","article-title":"Interactions of graphene derivatives with glutamate-neurotransmitter: a parallel first principles-Docking investigation","volume":"88","author":"Tonel","year":"2019","journal-title":"J. Mol. Graph. Model"},{"key":"10.1016\/j.biopha.2021.111515_bib27","article-title":"Glutamate mechanisms underlying opiate memories","volume":"2","author":"Peters","year":"2012","journal-title":"Cold Spring Harb. Perspec. Med."},{"key":"10.1016\/j.biopha.2021.111515_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Prac. Perspec."},{"key":"10.1016\/j.biopha.2021.111515_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/syn.890190309","article-title":"Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress","volume":"19","author":"Persico","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.biopha.2021.111515_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tins.2005.06.005","article-title":"The many faces of CREB","volume":"28","author":"Carlezon","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2021.111515_bib31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/sj.npp.1300416","article-title":"Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice","volume":"29","author":"Valverde","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2021.111515_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13556210412331308994","article-title":"Morphine\u2010induced changes of gene expression in the brain","volume":"10","author":"Ammon\u2010Treiber","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2021.111515_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","article-title":"CREB: a multifaceted regulator of neuronal plasticity and protection","volume":"116","author":"Sakamoto","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111515_bib34","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.4701-05.2006","article-title":"Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors","volume":"26","author":"Han","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2021.111515_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.55782\/ane-2000-1376","article-title":"Effect of opioids on Ca2+\/cAMP responsive element binding protein","volume":"60","author":"Bilecki","year":"2000","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.biopha.2021.111515_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072578","article-title":"Dopamine modulates acetylcholine release via octopamine and CREB signaling in Caenorhabditis elegans","volume":"8","author":"Suo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111515_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbrainres.2005.07.008","article-title":"Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males","volume":"140","author":"Cheng","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.biopha.2021.111515_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/revneuro-2016-0078","article-title":"Peripheral levels of BDNF and opiate-use disorder: literature review and update","volume":"28","author":"Palma-\u00c1lvarez","year":"2017","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.biopha.2021.111515_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fncel.2018.00273","article-title":"Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains","volume":"12","author":"Porcher","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111515_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2014.04.048","article-title":"Increased serum brain-derived neurotrophic factor levels during opiate withdrawal","volume":"571","author":"Zhang","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2021.111515_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/cib.13761","article-title":"Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development","volume":"4","author":"Martin","year":"2011","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.biopha.2021.111515_bib42","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1097\/00001756-200108280-00017","article-title":"BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes","volume":"12","author":"Pascual","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2021.111515_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.comppsych.2015.11.010","article-title":"Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26 weeks of withdrawal","volume":"65","author":"Zhang","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111515_bib44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/0269881107078491","article-title":"Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor","volume":"21","author":"Angelucci","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2021.111515_bib45","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/0269881111411332","article-title":"Serum levels of BDNF are associated with craving in opiate-dependent patients","volume":"25","author":"Heberlein","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2021.111515_bib46","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s11064-019-02851-z","article-title":"and Arc mRNA expression in the hippocampus of rats after administration of morphine","volume":"44","author":"Rouhani","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111515_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nn.3932","article-title":"Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area","volume":"18","author":"Koo","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2021.111515_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2217\/nnm-2017-0365","article-title":"Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion","volume":"13","author":"Shobo","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2021.111515_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2021.111515_bib50","first-page":"478","article-title":"Pharmacokinetics of sustained-release analgesics in mice","volume":"53","author":"Kendall","year":"2014","journal-title":"J. Am. Assoc. Lab. Animal Sci."},{"key":"10.1016\/j.biopha.2021.111515_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0928-0987(02)00009-X","article-title":"Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine","volume":"15","author":"Gopal","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111515_bib52","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1360-0443.2011.03424.x","article-title":"The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine\/naloxone tablets in opioid abusers","volume":"106","author":"Middleton","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.biopha.2021.111515_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10337-011-2095-2","article-title":"Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by LC-MS-MS","volume":"74","author":"Chiang","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.biopha.2021.111515_bib54","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuropharm.2007.01.005","article-title":"The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference","volume":"52","author":"Marquez","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111515_bib55","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.2042-7158.2012.01555.x","article-title":"Intranasal delivery of insulin via the olfactory nerve pathway","volume":"64","author":"Renner","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111515_bib56","first-page":"387","article-title":"Effect of crocin carotenoid on BDNF and CREB gene expression in brain ventral tegmental area of morphine treated rats, Asian Pacific Journal of Tropical Biomedicine","volume":"8","author":"Rezai","year":"2018"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:23:41Z","timestamp":1760099021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":56,"alternative-id":["S0753332221003000"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111515","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111515"}}